Simplex Trading
DMAC icon

Simplex Trading’s DiaMedica Therapeutics DMAC Stock Holding History

Simplex Trading’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25K Sell
3,700
-300
-8% -$2.38K ﹤0.01% 6576
2025
Q4 		$31.8K Buy
4,000
+300
+8% +$2.24K ﹤0.01% 6060
2025
Q3 		$25K Buy
3,700
+2,800
+311% +$15.2K ﹤0.01% 7126
2025
Q2 		$3K Buy
+900
New +$3.51K ﹤0.01% 7951
2025
Q1 		– Sell
-39,800
Closed -$216K – 8720
2024
Q4 		$216K Buy
39,800
+100
+0.3% +$472 ﹤0.01% 4432
2024
Q3 		$166K Buy
39,700
+38,100
+2,381% +$141K ﹤0.01% 4704
2024
Q2 		$4K Sell
1,600
-100
-6% -$274 ﹤0.01% 7969
2024
Q1 		$4K Buy
+1,700
New +$4.94K ﹤0.01% 8102
2023
Q3 		– Sell
-5,300
Closed -$22K – 8883
2023
Q2 		$22K Buy
+5,300
New +$12.9K ﹤0.01% 6663
2022
Q4 		– Sell
-1,200
Closed -$1K – 9415
2022
Q3 		$1K Sell
1,200
-17,200
-93% -$26.9K ﹤0.01% 9511
2022
Q2 		$37K Buy
18,400
+7,100
+63% +$16.6K ﹤0.01% 6875
2022
Q1 		$28K Sell
11,300
-11,000
-49% -$31.2K ﹤0.01% 7838
2021
Q4 		$83K Buy
+22,300
New +$87.6K ﹤0.01% 6529

Other funds holding DMAC

CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Simplex Trading's DMAC Position: Q1 2026 in Review

Simplex Trading sold out of DiaMedica Therapeutics (DMAC) in Q1 2026, closing a stake of 12,132 shares — an estimated $96.1K sold.

Simplex Trading first reported a position in DMAC in Q1 2021 and held it in 14 quarters. The position peaked at $96.6K in Q4 2025. 98 funds tracked by Wall St. Rank hold DMAC as of Q1 2026.

  • Simplex Trading reported no remaining DiaMedica Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 12,132 DiaMedica Therapeutics shares in Q1 2026, an estimated $96.1K.
  • Simplex Trading first reported a position in DiaMedica Therapeutics in Q1 2021 and held it in 14 quarters.
  • Simplex Trading's DiaMedica Therapeutics position peaked at $96.6K in Q4 2025.
  • 98 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.